Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1999

Mahmoud NN, Dannenberg AJ, Bilinski RT, Mestre JR, Chadburn A, Churchill M, et al. Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis. 1999;20(2):299-303.

Magro CM, Crowson AN. Pseudoporphyria associated with Relafen therapy. J Cutan Pathol. 1999;26(1):42-7.

Tyler JK, Kadonaga JT. The "dark side" of chromatin remodeling: repressive effects on transcription. Cell. 1999;99(5):443-6.

Johnson JM, Jessurun J, Leonard A. Sacrococcygeal ependymoma: case report and review of the literature. J Pediatr Surg. 1999;34(9):1405-7.

Lallena MJ, Diaz-Meco MT, Bren G, Payá CV, Moscat J. Activation of IkappaB kinase beta by protein kinase C isoforms. Mol Cell Biol. 1999;19(3):2180-8.

Standaert ML, Bandyopadhyay G, Perez L, Price D, Galloway L, Poklepovic A, et al. Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem. 1999;274(36):25308-16.

Sharifi S, Murphy M, Loda M, Pinkus GS, Khettry U. Nodular lymphoid lesion of the liver: an immune-mediated disorder mimicking low-grade malignant lymphoma. Am J Surg Pathol. 1999;23(3):302-8.

Jagura-Burdzy G, Macartney DP, Zatyka M, Cunliffe L, Cooke D, Huggins C, et al. Repression at a distance by the global regulator KorB of promiscuous IncP plasmids. Mol Microbiol. 1999;32(3):519-32.

Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK, et al. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) s. J Biol Chem. 1999;274(11):7341-50.

Qin L, Ding Y, Bromberg JS. Use of gene therapy for tolerogenic signals. Transplant Proc. 1999;31(1-2):882-3.